LEADER 05140nam 22007334a 450 001 9910808144703321 005 20200520144314.0 010 $a0-19-770826-9 010 $a1-280-83504-4 010 $a9786610835041 010 $a0-19-803245-5 010 $a1-4237-4569-8 024 7 $a10.1093/oso/9780195141733.001.0001 035 $a(CKB)1000000000459026 035 $a(EBL)281481 035 $a(OCoLC)476026750 035 $a(SSID)ssj0000219308 035 $a(PQKBManifestationID)11190137 035 $a(PQKBTitleCode)TC0000219308 035 $a(PQKBWorkID)10227770 035 $a(PQKB)11673391 035 $a(Au-PeEL)EBL281481 035 $a(CaPaEBR)ebr10269102 035 $a(CaONFJC)MIL83504 035 $a(OCoLC)62866815 035 $a(MiAaPQ)EBC281481 035 $a(OCoLC)1406785143 035 $a(StDuBDS)9780197708262 035 $a(EXLCZ)991000000000459026 100 $a20020222d2003 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aPediatric psychopharmacology $eprinciples and practice /$fedited by Andres Martin ... [et al.] 205 $a1st ed. 210 $aOxford ;$aNew York $cOxford University Press$dc2003 215 $a1 online resource (814 p.) 225 1 $aOxford scholarship online 300 $aPreviously issued in print: 2002. 311 $a0-19-514173-3 320 $aIncludes bibliographical references and index. 327 $aContents; Contributors; SECTION I: BIOLOGICAL BASES OF PEDIATRIC PSYCHOPHARMACOLOGY; I-A: DEVELOPMENTAL PRINCIPLES OF NEUROBIOLOGY AND PSYCHOPHARMACOLOGY; 1. Overview of Brain Development; 2. Synaptic Function and Biochemical Neuroanatomy; 3. Mechanisms of Signal Transduction and Adaptation to Psychotropic Drug Action; 4. Pharmacokinetics I: Developmental Principles; 5. Pharmacokinetics II: Cytochrome P450-Mediated Drug Interactions; I-B: GENETIC PRINCIPLES; 6. Molecular Genetics; 7. Pharmacogenetics; I-C: DEVELOPMENTAL PSYCHOPATHOLOGY 327 $a8. Neurobiology of Attention Regulation and its Disorders9. Neurobiology of Early-Life Stress and its Disorders; 10. Neurobiology of Early-Onset Mood Disorders; 11. Neurobiology of Early-Onset Anxiety Disorders; 12. Neurobiology of Obsessive-Compulsive Disorder; 13. Neurobiology of Tic Disorders, Including Tourette's Syndrome; 14. Neurobiology of Immune-Mediated Neuropsychiatric Disorders; 15. Neurobiology of Childhood Schizophrenia and Related Disorders; 16. Neurobiology of Affiliation: Implications for Autism Spectrum Disorders; 17. Neurobiology of Aggression 327 $a18. Neurobiology of Eating Disorders19. Neurobiology of Substance Abuse and Dependence Disorders; SECTION II: SOMATIC INTERVENTIONS; II-A: PSYCHOTROPIC AGENTS; 20. Stimulants; 21. Adrenergic Agonists: Clonidine and Guanfacine; 22. Antidepressants I: Selective Serotonin Reuptake Inhibitors; 23. Antidepressants II: Tricyclic Agents; 24. Antidepressants III: Other Agents; 25. Mood Stabilizers: Lithium and Anticonvulsants; 26. Antipsychotic Agents: Traditional and Atypical; 27. Anxiolytics: Benzodiazepines, Buspirone, and Others; 28. Miscellaneous Compounds: Beta-Blockers and Opiate Antagonists 327 $aII-B: OTHER SOMATIC INTERVENTIONS29. Complementary and Alternative Medicine in Pediatric Psychopharmacology; 30. Electroconvulsive Therapy and Transcranial Magnetic Stimulation; SECTION III: ASSESSMENT AND TREATMENT; III-A: GENERAL PRINCIPLES; 31. Clinical Assessment of Children and Adolescents Treated Pharmacologically; 32. Clinical Instruments and Scales in Pediatric Psychopharmacology; 33. Thinking About Prescribing: The Psychology of Psychopharmacology; 34. Combining Pharmacotherapy and Psychotherapy: An Evidence-Based Approach; III-B: SPECIFIC DISORDERS AND SYNDROMES 327 $a35. Attention-Deficit Hyperactivity Disorder36. Depressive Disorders; 37. Bipolar Disorder; 38. Anxiety Disorders; 39. Obsessive-Compulsive Disorder; 40. Tourette's Syndrome and Other Tic Disorders; 41. Early-Onset Schizophrenia; 42. Autistic and Other Pervasive Developmental Disorders; 43. Post-traumatic Stress Disorder; 44. Eating Disorders; III-C: SPECIAL CLINICAL POPULATIONS; 45. Substance-Abusing Youths; 46. Individuals with Mental Retardation; 47. The Medically Ill Child or Adolescent; 48. Psychopharmacology During Pregnancy: Infant Considerations 327 $a49. Psychopharmacological Treatment of Preschoolers 330 8 $aThis is a comprehensive text on the use of medication in the treatment of children and adolescents with serious neuropsychiatric disorders. It reconciles recent research findings with good clinical practice. 410 0$aOxford scholarship online. 606 $aPediatric psychopharmacology 606 $aPsychotropic drugs 615 0$aPediatric psychopharmacology. 615 0$aPsychotropic drugs. 676 $a615/.78 701 $aMartin$b Andres$01654207 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910808144703321 996 $aPediatric psychopharmacology$94193041 997 $aUNINA